1. Home
  2. VIR vs ASTE Comparison

VIR vs ASTE Comparison

Compare VIR & ASTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • ASTE
  • Stock Information
  • Founded
  • VIR 2016
  • ASTE 1972
  • Country
  • VIR United States
  • ASTE United States
  • Employees
  • VIR N/A
  • ASTE N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • ASTE Construction/Ag Equipment/Trucks
  • Sector
  • VIR Health Care
  • ASTE Industrials
  • Exchange
  • VIR Nasdaq
  • ASTE Nasdaq
  • Market Cap
  • VIR 844.9M
  • ASTE 777.8M
  • IPO Year
  • VIR 2019
  • ASTE N/A
  • Fundamental
  • Price
  • VIR $5.23
  • ASTE $38.89
  • Analyst Decision
  • VIR Strong Buy
  • ASTE Hold
  • Analyst Count
  • VIR 7
  • ASTE 1
  • Target Price
  • VIR $32.86
  • ASTE $41.00
  • AVG Volume (30 Days)
  • VIR 1.4M
  • ASTE 145.1K
  • Earning Date
  • VIR 07-31-2025
  • ASTE 08-06-2025
  • Dividend Yield
  • VIR N/A
  • ASTE 1.34%
  • EPS Growth
  • VIR N/A
  • ASTE N/A
  • EPS
  • VIR N/A
  • ASTE 0.66
  • Revenue
  • VIR $20,861,000.00
  • ASTE $1,325,300,000.00
  • Revenue This Year
  • VIR N/A
  • ASTE $5.51
  • Revenue Next Year
  • VIR N/A
  • ASTE $3.99
  • P/E Ratio
  • VIR N/A
  • ASTE $58.71
  • Revenue Growth
  • VIR N/A
  • ASTE 1.99
  • 52 Week Low
  • VIR $4.32
  • ASTE $28.46
  • 52 Week High
  • VIR $14.45
  • ASTE $42.79
  • Technical
  • Relative Strength Index (RSI)
  • VIR 50.23
  • ASTE 45.68
  • Support Level
  • VIR $5.02
  • ASTE $39.19
  • Resistance Level
  • VIR $5.34
  • ASTE $41.23
  • Average True Range (ATR)
  • VIR 0.25
  • ASTE 1.01
  • MACD
  • VIR 0.03
  • ASTE -0.25
  • Stochastic Oscillator
  • VIR 47.53
  • ASTE 14.69

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

Share on Social Networks: